Literature DB >> 12101239

Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator.

Suzanne E Wardell1, Viroj Boonyaratanakornkit, James S Adelman, Ami Aronheim, Dean P Edwards.   

Abstract

The progesterone receptor (PR) contains two transcription activation function (AF) domains, constitutive AF-1 in the N terminus and AF-2 in the C terminus. AF-2 activity is mediated by a hormone-dependent interaction with a family of steroid receptor coactivators (SRCs). SRC-1 can also stimulate AF-1 activity through a secondary domain that interacts simultaneously with the primary AF-2 interaction site. Other protein interactions and mechanisms that mediate AF-1 activity are not well defined. By interaction cloning, we identified an AP-1 family member, Jun dimerization protein 2 (JDP-2), as a novel PR-interacting protein. JDP-2 was first defined as a c-Jun interacting protein that functions as an AP-1 repressor. PR and JDP-2 interact directly in vitro through the DNA binding domain (DBD) of PR and the basic leucine zipper (bZIP) region of JDP-2. The two proteins also physically associate in mammalian cells, as detected by coimmunoprecipitation, and are recruited in vivo to a progesterone-inducible target gene promoter, as detected by a chromatin immunoprecipitation (ChIP) assay. In cell transfection assays, JDP-2 substantially increased hormone-dependent PR-mediated transactivation and worked primarily by stimulating AF-1 activity. JDP-2 is a substantially stronger coactivator of AF-1 than SRC-1 and stimulates AF-1 independent of SRC-1 pathways. The PR DBD is necessary but not sufficient for JDP-2 stimulation of PR activity; the DBD and AF-1 are required together. JDP-2 lacks an intrinsic activation domain and makes direct protein interactions with other coactivators, including CBP and p300 CBP-associated factor (pCAF), but not with SRCs. These results indicate that JDP-2 stimulates AF-1 activity by the novel mechanism of docking to the DBD and recruiting or stabilizing N-terminal PR interactions with other general coactivators. JDP-2 has preferential activity on PR among the nuclear receptors tested and is expressed in progesterone target cells and tissues, suggesting that it has a physiological role in PR function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12101239      PMCID: PMC133955          DOI: 10.1128/MCB.22.15.5451-5466.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription.

Authors:  E J Schwarz; M J Reginato; D Shao; S L Krakow; M A Lazar
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

2.  A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors.

Authors:  B Le Douarin; A L Nielsen; J M Garnier; H Ichinose; F Jeanmougin; R Losson; P Chambon
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

3.  Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells.

Authors:  D Metzger; S Ali; J M Bornert; P Chambon
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

4.  A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex.

Authors:  R B Lanz; N J McKenna; S A Onate; U Albrecht; J Wong; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

5.  16 alpha-substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity.

Authors:  B L Wagner; G Pollio; S Leonhardt; M C Wani; D Y Lee; M O Imhof; D P Edwards; C E Cook; D P McDonnell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

6.  A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform.

Authors:  C A Sartorius; M Y Melville; A R Hovland; L Tung; G S Takimoto; K B Horwitz
Journal:  Mol Endocrinol       Date:  1994-10

7.  Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta.

Authors:  B Stein; M X Yang
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

8.  AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor.

Authors:  M Boruk; J G Savory; R J Haché
Journal:  Mol Endocrinol       Date:  1998-11

9.  Sequence and characterization of a coactivator for the steroid hormone receptor superfamily.

Authors:  S A Oñate; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

Review 10.  The nuclear receptor superfamily: the second decade.

Authors:  D J Mangelsdorf; C Thummel; M Beato; P Herrlich; G Schütz; K Umesono; B Blumberg; P Kastner; M Mark; P Chambon; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

View more
  39 in total

Review 1.  Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.

Authors:  Raj Kumar; Iain J McEwan
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

2.  Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation.

Authors:  Hany Abdel-Hafiz; Michelle L Dudevoir; Kathryn B Horwitz
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

3.  Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha.

Authors:  Harish Srinivas; Dianren Xia; Nicole L Moore; Ivan P Uray; Heetae Kim; Long Ma; Nancy L Weigel; Powel H Brown; Jonathan M Kurie
Journal:  Biochem J       Date:  2006-05-01       Impact factor: 3.857

4.  Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells.

Authors:  Erik C Mazur; Yasmin M Vasquez; Xilong Li; Ramakrishna Kommagani; Lichun Jiang; Rui Chen; Rainer B Lanz; Ertug Kovanci; William E Gibbons; Francesco J DeMayo
Journal:  Endocrinology       Date:  2015-03-17       Impact factor: 4.736

5.  Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400.

Authors:  Suzanne E Wardell; Ramesh Narayanan; Nancy L Weigel; Dean P Edwards
Journal:  Mol Endocrinol       Date:  2009-12-11

6.  Differential targeting of the stress mitogen-activated protein kinases to the c-Jun dimerization protein 2.

Authors:  Sigal Katz; Ami Aronheim
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

7.  Bifidobacterium bifidum actively changes the gene expression profile induced by Lactobacillus acidophilus in murine dendritic cells.

Authors:  Gudrun Weiss; Simon Rasmussen; Lisbeth Nielsen Fink; Hanne Jarmer; Birgit Nøhr Nielsen; Hanne Frøkiaer
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

Review 8.  Nuclear receptor coactivator function in reproductive physiology and behavior.

Authors:  Heather A Molenda; Caitlin P Kilts; Rachel L Allen; Marc J Tetel
Journal:  Biol Reprod       Date:  2003-07-09       Impact factor: 4.285

9.  Activation of alternative Jdp2 promoters and functional protein isoforms in T-cell lymphomas by retroviral insertion mutagenesis.

Authors:  Mads Heilskov Rasmussen; Bruce Wang; Matthias Wabl; Anders Lade Nielsen; Finn Skou Pedersen
Journal:  Nucleic Acids Res       Date:  2009-06-05       Impact factor: 16.971

10.  Molecular characterization of SMILE as a novel corepressor of nuclear receptors.

Authors:  Yuan-Bin Xie; Balachandar Nedumaran; Hueng-Sik Choi
Journal:  Nucleic Acids Res       Date:  2009-05-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.